Corgenix Medical Corporation, a VHFC partner, and worldwide developer of diagnostics test kits, has been awarded two grants totaling $818,000 to advance the development of an Ebola rapid diagnostic test kit.
With the ebola epidemic still out of control in West Africa, we applaud Time Magazine’s decision to honor the heroic work of ebola fighters worldwide. This fight is far from over, and it is important that we pay tribute to, recognize and continue to support the selfless work by local healthcare workers, scientists, ministries of health, and aid organizations in Guinea, Liberia, and Sierra Leone.
A feared hallmark of Ebola – uncontrolled bleeding – is a rare symptom in the current outbreak, according to an article in this week’s New England Journal of Medicine that is the largest clinical analysis to date of the West African epidemic.
It is with great sadness that the VHFC mourns the loss of our colleague and friend Dr. Sheik Humarr Khan, Physician In-Charge of the Lassa Fever Program at Kenema Government Hospital in Sierra Leone. Dr. Khan was a leading expert in the clinical care of viral hemorrhagic fevers, devoted to the care of his fellow nationals. Dr.
KENEMA, Sierra Leone - The Viral Hemorrhagic Fever Consortium (VHFC) remains deeply concerned about the ongoing outbreak of Ebola Virus Disease (EVD) in West Africa. As of 27 June 2014, the WHO reports 176 cases and 46 deaths from confirmed cases in Sierra Leone.
Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, and VHFC partner, has been awarded a three-year, $2.9 million National Institutes of Health (NIH) grant to advance the development of an Ebola rapid diagnostic test kit.
In an interview on National Public Radio, Drs. Robert Garry (Tulane University) and Thomas Geisbert (University of Texas Medical Branch) discuss the devastation caused by the raging Ebola outbreak in West Africa, and the challenges health workers are facing.
In a recent article by Today.com, Dr. Robert Garry discusses the growing threat of Ebola in Sierra Leone. Dr. Garry, a researcher from Tulane University, has worked on building research capacity on viral hemorrhagic fevers in Sierra Leone for a decade.